69388-84-7CC1(C)[C@H](C(=O)[O-])N2C(=O)C[C@H]2S1(=O)=O.[Na+]NKZMPZCWBSWAOX-IBTYICNHSA-MSulbactam sodium is the organic sodium salt of sulbactam. It is a beta-lactam antibiotic and an organic sodium salt. It contains a sulbactam(1-).
FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
White Solid
This chemical does not meet GHS hazard criteria for 2.6% (1 of 38) of reports.
Danger
H317 (10.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]
P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P319, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Substances that inhibit the growth or reproduction of BACTERIA.
Endogenous substances and drugs that inhibit or block the activity of BETA-LACTAMASES.
개요Sulbactam sodium is a parenterally-active, β-lactamase inhibitor recently introduced as a 1: 1 combination product with cefoperazone. Like clavulanic acid, the first agent of this type to b e introduced, sulbactam enhances the effectiveness of β-lactam antibiotics against resistant strains.
용도A semi-synthetic β-lactamase inhibitor. It is used in combination with β-lactam antibiotics as antibacterial.
일반 설명Sulbactam was synthesized by Pfizer Research Laboratories in 1977 in the course of screening for β-lactamase inhibitors. It shows strong activity against penicillinase and moderate activity against cephalosporinase. Sulbactam itself shows activity against some gramnegative bacteria but no activity against most pathogenic bacteria. The use of sulbactam in combination with cefoperazone, which is partially hydrolyzed by penicillinase, is under study along with its use as an esterified complex with ampicillin (sultamicillin) for therapy of cefoperazone-ampicillin-resistant infections.
불러오는 중…
69388-84-7DTXSID401026661CHEMBL1200944CHEBI:157785